is bpc 157 a growth hormone 10 questions to ask your doctor about peptides Peptides are having a moment.

That is far weaker than a Phase 1 human trial

However, as Miller says, the research linking B12 with bone health only shows an association, not a cause-effect relationship

While it has not received FDA approval for therapeutic use, it is available for research purposes and is used in metabolic optimization protocols

Subcutaneous planning from a 50 mg vial reconstituted with 3.0 mL BAC water (~16.7 mg/mL) Phase Days 12 (tolerance) Daily dose 2.5 mg once daily Units on U-100 syringe 15 units Volume 0.15 mL Phase Days 3+ (standard) Daily dose 5 mg once daily Units on U-100 syringe 30 units Volume 0.30 mL Phase Split option (BID) Daily dose 2.5 mg twice daily Units on U-100 syringe 15 units each Volume 0.15 mL each Subcutaneous doses are much smaller than oral doses because of injection volume limits and because direct subQ absorption skips the gut

[DOI] [PMC free article] [PubMed] [Google Scholar] [124].Biswas S, Bieber K, Manz RA